title: a1 adenosine receptor-mediated girk channels ......172 were rinsed in pbs buffer, and then...

47
1 Title: A1 adenosine receptor-mediated GIRK channels contributes to the resting 1 conductance of CA1 neurons in the dorsal hippocampus 2 3 4 5 Authors: Chung Sub Kim and Daniel Johnston 6 Author contributions: C.S.K and D.J. designed research; C.S.K performed research; 7 C.S.K. analyzed data; C.S.K. and D.J. wrote the paper. 8 9 Department of Neuroscience and Center for Learning and Memory 10 University of Texas at Austin, Austin, TX 78712, USA. 11 12 Running Head: Coupling of A1ARs to GIRK in dorsal CA1 neurons 13 14 Daniel Johnston, Ph.D. 15 Center for Learning and Memory 16 University of Texas at Austin 17 100 E. 24 th Street 18 Austin, TX 78712-0805 19 Phone: 512-232-6564 20 E-mail: [email protected] 21 22 23 Articles in PresS. J Neurophysiol (February 4, 2015). doi:10.1152/jn.00951.2014 Copyright © 2015 by the American Physiological Society.

Upload: others

Post on 21-Oct-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

  • 1

    Title: A1 adenosine receptor-mediated GIRK channels contributes to the resting 1

    conductance of CA1 neurons in the dorsal hippocampus 2

    3

    4

    5

    Authors: Chung Sub Kim and Daniel Johnston 6

    Author contributions: C.S.K and D.J. designed research; C.S.K performed research; 7

    C.S.K. analyzed data; C.S.K. and D.J. wrote the paper. 8

    9

    Department of Neuroscience and Center for Learning and Memory 10

    University of Texas at Austin, Austin, TX 78712, USA. 11

    12

    Running Head: Coupling of A1ARs to GIRK in dorsal CA1 neurons 13

    14

    Daniel Johnston, Ph.D. 15

    Center for Learning and Memory 16

    University of Texas at Austin 17

    100 E. 24th Street 18

    Austin, TX 78712-0805 19

    Phone: 512-232-6564 20

    E-mail: [email protected] 21

    22

    23

    Articles in PresS. J Neurophysiol (February 4, 2015). doi:10.1152/jn.00951.2014

    Copyright © 2015 by the American Physiological Society.

  • 2

    Number of pages: 40 24

    Number of figures: 7 25

    Number of tables: 9 26

    Number of words for Abstract: 185 words 27

    Number of words for Introduction: 413 words 28

    Number of words for Discussion: 1367 words 29

    30

    Acknowledgments: This study was supported by grants from National Institutes of 31

    Health NS084473 and NS077477 (DJ). We thank Drs. Rick Gray, Brian Kalmbach, 32

    and Darrin Brager for reviewing the manuscript and comments throughout this study. 33

    We also thank Drs. Randy Chitwood, Kelly Dougherty, and Ann Clemens for giving 34

    helpful comments. 35

    36

    Conflict of Interest: The authors declare no competing financial interests 37

    38

    39

    40

    41

    42

    43

    44

  • 3

    Abstract 45

    The dorsal and ventral hippocampi are functionally and anatomically distinct. 46

    Recently, we reported that dorsal CA1 neurons have a more hyperpolarized resting 47

    membrane potential (RMP), a lower input resistance (Rin), and fire fewer action 48

    potentials for a given current injection than ventral CA1 neurons. Differences in the 49

    hyperpolarizing HCN conductance between dorsal and ventral neurons have been 50

    reported, but these differences cannot fully account for the different resting 51

    properties of these neurons. Here we show that coupling of A1 adenosine receptors 52

    (A1ARs) to G-protein coupled inwardly rectifying potassium (GIRK) conductance 53

    contributes to the intrinsic membrane properties of dorsal CA1 neurons but not 54

    ventral CA1 neurons. The block of GIRKs with either barium or the more specific 55

    blocker tertiapin-Q revealed that there is more resting GIRK conductance in dorsal 56

    CA1 neurons compared to ventral CA1 neurons. We found that the higher resting 57

    GIRK conductance in dorsal CA1 neurons was mediated by tonic A1 adenosine 58

    receptor activation. These results demonstrate that the different resting membrane 59

    properties between dorsal and ventral CA1 neurons are due in part to higher 60

    adenosine A1 receptor-mediated GIRK activity in dorsal CA1 neurons. 61

    62

    63

    64

    65

    66

    Keywords: Dorsal and ventral hippocampus; A1 adenosine receptors; GIRK 67

  • 4

    Introduction 68

    The rodent hippocampus can be divided into dorsal and ventral regions based 69

    on biochemical, anatomical, and behavioral observations (van Groen and Wyss 70

    1990; Moser and Moser 1998; Dong et al. 2009; Fanselow and Dong 2010). Until 71

    recently, the electrophysiological properties of CA1 pyramidal neurons along the 72

    longitudinal hippocampal axis were often thought to be uniform. However, growing 73

    evidence demonstrates that intrinsic membrane properties of CA1 neurons from the 74

    dorsal and ventral hippocampus are significantly different (Dougherty et al. 2012; 75

    Marcelin et al. 2012a). For example, dorsal neurons have a more hyperpolarized 76

    resting membrane potential (RMP) and a lower input resistance (Rin). As such, they 77

    fire fewer action potentials in response to a given current injection compared to 78

    ventral neurons (Dougherty et al. 2012). Although functional Ih is different between 79

    dorsal and ventral CA1 neurons (Dougherty et al. 2013), the intrinsic membrane 80

    properties of these neurons cannot be fully explained by Ih-related differences. 81

    Voltage-gated ion channels and neuronal morphology contribute to the 82

    intrinsic membrane properties of neurons (Hoffman et al. 1997; Magee 1998; Vetter 83

    et al. 2001; Spruston 2008). Differences in RMP and Rin between dorsal and ventral 84

    CA1 neurons may therefore be explained in part by the expression of voltage-gated 85

    ion channels. Given the more hyperpolarized membrane potential and lower Rin in 86

    dorsal neurons compared to ventral neurons, we hypothesized that dorsal CA1 87

    neurons possess a greater resting potassium conductance than ventral CA1 neurons. 88

    Furthermore, inwardly rectifying K+ (IRK) channels and G protein-coupled inwardly 89

    rectifying K+ (GIRK) channels are highly expressed in the CA1 pyramidal neurons 90

  • 5

    (Karschin et al. 1996; Liao et al. 1996; Ponce et al. 1996; Drake et al. 1997). G 91

    protein-coupled inwardly rectifying K+ channels (GIRKs) are activated by Gi/o-coupled 92

    metabotropic receptors and hyperpolarize the membrane potential and decrease Rin, 93

    providing a decrease in neuronal excitability (Andrade et al. 1986; Mihara et al. 1987; 94

    North 1989; Luscher et al. 1997). 95

    In this study, we investigated the resting conductances in dorsal and ventral 96

    CA1 pyramidal neurons. We found that dorsal neurons have more Ba2+-sensitive 97

    conductance compared to ventral neurons. Application of tertiapin-Q revealed that 98

    this greater Ba2+-sensitive conductance in dorsal CA1 neurons was mediated by 99

    GIRK channels. Finally, we found that this higher resting GIRK conductance in dorsal 100

    neurons was mediated by tonic activation of A1 adenosine receptors (A1ARs). 101

    Together, our results suggest that higher resting GIRK conductance activated by A1 102

    adenosine receptors is present in dorsal but not ventral CA1 neurons and contributes 103

    to intrinsic membrane properties of these neurons. 104

    105

    106

    107

    108

    109

    110

    111

    112

    113

  • 6

    Materials and Methods 114

    Animals. Hippocampal slices from the dorsal and ventral poles were prepared from 115

    11- to 13-week-old male Sprague Dawley rats housed 2-3 per cage on a 12 hr light 116

    schedule (on 7:00 A.M. off 7:00 P.M.) with ad libitum access to water and food. All 117

    procedures involving animals were approved by the University of Texas at Austin 118

    Institutional Animal Care and Use Committee (IACUC). 119

    Drugs. Barium chloride was purchased from Fisher Scientific. Tertiapin-Q was 120

    purchased from Alomone Lab. DPCPX, ZD7288, 2’ME-CCPA, D-APV, Gabazine, 121

    CGP 55845, and DNQX were purchased from Abcam Inc. 122

    Slice preparation. Rats were anesthetized with a lethal dose of a ketamine/xylazine 123

    mixture (90/10mg/ml) and transcardially perfused with ice-cold artificial cerebral 124

    spinal fluid (aCSF) composed of (in mM): 2.5 KCl, 1.25 NaH2PO4 , 25 NaHCO3, 0.5 125

    CaCl2, 7 MgCl2, 7 dextrose, 210 sucrose, 1.3 ascorbic acid, and 3 sodium pyruvate, 126

    bubbled with 95% O2 - 5% CO2. The brain was then removed, and hemisected along 127

    the longitudinal fissure. For dorsal hippocampal slices, a blocking cut was made at 128

    20o - 30o from the posterior coronal plane and collected at the anterior end of the 129

    forebrain. Ventral hippocampal slices were made from horizontal section. 300 μm 130

    thick hippocampal slices were made in ice-cold aCSF using a vibrating microtome 131

    (Microslicer DTK-Zero1, DSK, Kyoto, Japan). Slices were then transferred to a 132

    holding chamber for 30 min at 35oC containing (in mM) 125 NaCl, 2.5 KCl, 1.25 133

    NaH2PO4 , 25 NaHCO3, 2 CaCl2, 2 MgCl2, 12.5 dextrose, 1.3 ascorbic acid, and 3 134

    sodium pyruvate, bubbled with 95% O2 - 5% CO2. Slices were then incubated for at 135

    least 45 min at room temperature. 136

  • 7

    Whole-cell current-clamp recordings. 137

    Whole-cell current-clamp recordings were performed as previously described (Kim et 138

    al. 2012). Briefly, hippocampal slices were submerged in a recording chamber 139

    continuously perfused with aCSF containing synaptic blockers (D-APV 25 μM, 140

    Gabazine 2 μM, DNQX 20 μM) heated to 32-34 oC flowing at a rate of 1 to 2 ml/min. 141

    ACSF contained (in mM) 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 2 CaCl2, 1 142

    MgCl2, and 12.5 dextrose, bubbled with 95% O2 - 5% CO2. CA1 pyramidal neurons 143

    were visualized using a microscope (Zeiss Axioskop) fitted with differential 144

    interference contrast optics (Stuart et al. 1993). Patch pipettes (4–7 MΩ) were 145

    prepared with capillary glass (external diameter 1.65 mm, World Precision 146

    Instruments) using Flaming/Brown micropipette puller and filled with an internal 147

    solution containing (in mM) 120 K-gluconate, 20 KCl, 10 HEPES, 4 NaCl, 7 K2-148

    phosphocreatine, 4 Mg-ATP, 0.3 Na-GTP (pH 7.3 with KOH). Neurobiotin (Vector 149

    Labs) was used (0.1-0.2 %) for subsequent histological processing. Somatic whole-150

    cell current-clamp recordings were performed using a Dagan BVC-700A amplifier 151

    (Dagan, Minneapolis, MN). Electrical signals were filtered at 5 kHz, sampled at 152

    20 kHz, and digitized by an ITC-18 interface (HEKA Instruments Inc., Bellmore, NY) 153

    connected to a computer running custom software written in IGOR Pro 154

    (Wavemetrics). Experiments were terminated if the series resistance exceeded 30 155

    MΩ. Membrane potentials were corrected for liquid junction potentials (- 8mV). For 156

    tertiapin experiments, we used log-order increases in concentration (0.03, 0.3, and 2 157

    μM) 158

    Immunohistochemistry. Animals were anesthetized and perfused through the 159

  • 8

    ascending aorta using ice-cold artificial cerebral spinal fluid (aCSF) composed of (in 160

    mM): 2.5 KCl, 1.25 NaH2PO4 , 25 NaHCO3, 0.5 CaCl2, 7 MgCl2, 7 dextrose, 210 161

    sucrose, 1.3 ascorbic acid, and 3 sodium pyruvate, bubbled with 95% O2 - 5% CO2 162

    followed by 4% paraformaldehyde (PFA) in PBS described previously (Kim et al. 163

    2012). The brain was removed and fixed overnight in 4% PFA, and then transferred 164

    to 30% sucrose in PBS. Dorsal and ventral hippocampal slices were prepared on a 165

    cryostat and stored in cryoprotectant (30% sucrose, 30% ethylene glycol, 1% 166

    polyvinyl pyrrolidone, 0.05M sodium phosphate buffer) until processing for 167

    immunohistochemistry. Dorsal and ventral slices were briefly rinsed in PBS buffer, 168

    and incubated in 0.1% TritonX-100 for 30 min. Subsequently, slices were blocked in 169

    PBS solution containing 5 % normal goat serum, 0.03% TritonX-100 for 1hr, and then 170

    incubated in primary antibody diluted in blocking solution overnight at 4oC. Slices 171

    were rinsed in PBS buffer, and then incubated in secondary antibody for 1hr at room 172

    temperature. Primary antibodies in this study were used as follows; rabbit anti-Kir3.1 173

    (1:200, Alomone Labs), rabbit anti-Kir 3.2 (1:200, Alomone Labs), rabbit anti-A1 174

    adenosine receptors (1:200, Alomone Labs), and mouse anti-MAP2 (1:1000, Sigma-175

    Aldrich). 176

    Data analysis. Input resistance (Rin) was determined by the slope of the linear fit of 177

    the voltage-current plot from the steady-state voltage response to the injected 178

    current ranging from +10- to -150-pA (750 ms). FI curves were determined by 179

    plotting the number of action potentials against injected current (30-300 pA, for 750 180

    ms in 30 pA intervals). 181

    Statistical analyses. All data are expressed as mean ± SEM. Statistical 182

  • 9

    comparisons were performed using ANOVA (one-factor or two-factor) followed by 183

    Bonferrori post hoc test or Student’s t test (paired or unpaired) with GraphPad Prism 184

    software. *p< 0.05 was considered as statistically significant. 185

    186

    187

    188

    189

    190

    191

    192

    193

    194

    195

    196

    197

    198

    199

    200

  • 10

    Results 201

    Contribution of Ba2+-sensitive conductance to intrinsic membrane properties 202

    of dorsal CA1 neurons 203

    Our initial goal in this study was to explore the resting conductances that 204

    contribute to the intrinsic membrane properties of CA1 pyramidal neurons from the 205

    dorsal and ventral hippocampus. Although functional differences in Ih and distinct α-206

    subunit expression profiles of HCN1 and HCN2 were reported between dorsal and 207

    ventral CA1 neurons (Dougherty et al. 2013), Ih-related properties cannot fully 208

    account for the differences in intrinsic membrane properties between dorsal and 209

    ventral CA1 neurons (Dougherty et al. 2012). We therefore hypothesized that dorsal 210

    neurons might have a large resting potassium (K+) conductance contributed by 211

    inward rectifier-like K+ channels (Kir). A relatively low concentration of barium (50 μM 212

    Ba2+) is known to block Kir channels, but not many other K+ currents (Armstrong and 213

    Taylor 1980; Quayle et al. 1988; Sah 1996; Wang et al. 1998; Jin et al. 1999; Chen 214

    and Johnston 2005; Day et al. 2005). Because ZD7288 caused a gradual 215

    depolarization 10-15 min after the hyperpolarization of Vm (not shown), we first 216

    applied Ba2+ and then added of ZD7288 for 4 to 5 min (Dougherty et al. 2013) before 217

    switching back to the barium-containing aCSF. Membrane potential (Vm) and input 218

    resistance (Rin) at RMP were monitored during baseline, application of 50 μM Ba2+ 219

    and addition of 10 μM ZD7288 application in dorsal (Fig.1B) and ventral (Fig.1F) 220

    CA1 pyramidal neurons. 50 μM Ba2+ significantly depolarized the membrane 221

    potential in dorsal neurons (Fig.1, A and C; table 1), but not in ventral neurons (Fig.1, 222

    E and G; table 1). Addition of 10 μM ZD7288 produced a significant hyperpolarization 223

  • 11

    from baseline in ventral neurons (Fig.1, E and G; table 1), but not in dorsal neurons 224

    (Fig.1, A and C; table 1). Rin at RMP for dorsal neurons was significantly increased 225

    (Fig.1, A and D; table 1), but not for ventral neurons (Fig.1 E and H; table 1) after 50 226

    μM Ba2+ application. Addition of 10 μM ZD7288 led to a significant increase in Rin in 227

    dorsal (Fig.1 A and D; table 1) and ventral (Fig.1 E and H; table 1) neurons. For 228

    proper comparison between groups, Rin was measured at the same membrane 229

    potential. At a common membrane potential (-73 mV), 50 μM Ba2+ led to a significant 230

    increase in Rin for dorsal neurons (Fig.1I; table 2), but not for ventral neurons (Fig.1J; 231

    table 2). Vm (Fig.1K; table 2) and Rin (Fig.1L; table 2) were significantly different 232

    between dorsal and ventral neurons. This difference was absent when either IRKs 233

    alone were blocked or were blocked in combination with Ih (Fig.1, K and L; table 2). 234

    Because we observed significantly changes in voltage response (Vm) in response to 235

    the injected current from RMP and at -73 mV in the presence of Ba2+ in dorsal 236

    neurons (Fig.1 A and I), but not in ventral neurons (Fig.1 E and J), steady-state 237

    voltage-current (V-I) curves in control, Ba2+, and the difference between the two were 238

    plotted to better illustrate the Ba2+-sensitive conductance in the hyperpolarizing 239

    direction (Figs. 1M, N & O). The V-I curves before and after Ba2+ application were 240

    significantly different in dorsal neurons (Fig. 1M), but not ventral neurons (Fig. 1N) 241

    from RMP and at -73 mV, suggesting a greater Ba2+-sensitive conductance in dorsal 242

    neurons. 243

    244

    Comparison of basal GIRK activity between ventral and dorsal CA1 neurons 245

    Given the observation that significant changes in Vm and Rin (at RMP and at a 246

    common membrane potential) were observed following blockade of a Ba2+-sensitive 247

  • 12

    conductance in dorsal neurons (Fig.1), we next examined which ion conductance is 248

    responsible for the resting Ba2+-sensitive conductance. Inwardly rectifying potassium 249

    currents (Kir) are blocked by low concentrations of Ba2+ (Standen and Stanfield 1978; 250

    Williams et al. 1988; Gerber et al. 1991; Chen and Johnston 2005) , while tertiapin-Q 251

    is a specific GIRK channel blocker at nanomolar concentration (Jin et al. 1999). 252

    Because GIRK1 (Kir3.1) and GIRK2 (Kir3.2) heterotetrameric channels are 253

    predominantly expressed in the brain (Liao et al. 1996), we performed an 254

    immunohistochemical staining with antibodies against GIRK1 and GIRK2 in the 255

    dorsal and ventral hippocampus. To account for the longer radial axis in the CA1 256

    region of ventral hippocampus (Dougherty et al. 2012), the quantification of GIRK1 257

    and GIRK2 protein expression was normalized by distance (Fig. 2, A and C). 258

    Expression of GIRK1 and GIRK2 was higher in the somatic and distal dendritic 259

    regions of dorsal CA1 compared to ventral CA1 (Fig.2, B and D; p

  • 13

    that there were significant differences in the changes in Vm (Fig.2, F and G; table 3) 271

    and Rin (Fig.2, F and G; table 3) between dorsal and ventral neurons after either 0.3 272

    μM tertiapin-Q or 2 μM tertiapin-Q application. Based on these results, all 273

    subsequent tertiapin-Q experiments were performed using 0.3 µM. 274

    275

    The Ba2+-sensitive conductance in dorsal CA1 neurons in mostly mediated by 276

    GIRKs 277

    Because tertiapin-Q changed RMP and Rin in dorsal but not ventral CA1 278

    neurons (Fig.2), we next sought to determine whether the Ba2+-sensitive 279

    conductance in dorsal neurons was mediated by GIRKs. Vm and Rin (at RMP) were 280

    monitored during successive 0.3 μM tertiapin-Q and 50 μM Ba2+ application in dorsal 281

    (Fig.3B) and ventral (Fig.3F) neurons. Application of tertiapin-Q significantly 282

    depolarized (Fig.3, A and C; table 4) and increased Rin (Fig.3, A and D; table 4) of 283

    dorsal neurons. In contrast, tertiapin-Q had no significant effect on ventral neurons 284

    (Fig.3, G and H; table 4). There was no further change in either dorsal or ventral 285

    neurons when 50 μM Ba2+ was subsequently added to the bath (dorsal: Fig. 3, C and 286

    D, ventral: Fig.3, G and H; table 4). Blockade of both GIRK and Ba2+-sensitive 287

    conductances led to a significant depolarization (dorsal: Fig.3, A and C; ventral: Fig.3 288

    E and G; table 4) and an increased Rin (dorsal: Fig.3, A and D; ventral: Fig.3, E and 289

    H; table 4) in dorsal and ventral neurons. At a common membrane potential (-73 mV), 290

    a change in Rin for dorsal neurons was significantly increased in the presence of 0.3 291

    μM tertiapin-Q (Fig.3I; table 5), but not for ventral neurons (Fig.3J; table 5). When 292

    subsequent 50 μM Ba2+ was applied after blockade of GIRK conductance, there was 293

  • 14

    no further change in Rin in dorsal (Fig.3I; table 5) and ventral (Fig.3J; table 5) 294

    neurons. When both GIRK and Ba2+-sensitive conductances were blocked, Rin for 295

    dorsal neurons (Fig.3I; table 5) was significantly increased, but not for ventral 296

    neurons (Fig.3J; table 5). Action potentials evoked in response to depolarizing 297

    current steps (30-300 pA in 30 pA increments for 750 ms) were determined during 298

    successive 0.3 μM tertiapin-Q and 50 μM Ba2+ application at a common membrane 299

    potential (-73 mV) in dorsal (Fig.3K) and ventral (Fig.3L) neurons. As expected, 300

    tertiapin-Q application significantly increased action potential firing in dorsal neurons 301

    (Fig.3K), but had no effect on firing in ventral neurons (Fig.3L) compared to baseline. 302

    Addition of 50 μM Ba2+ had no further effects on firing in either dorsal (Fig.3K) or 303

    ventral (Fig.3L) neurons. 304

    305

    Comparison of basal GABAB receptor activity in dorsal and ventral CA1 306

    neurons 307

    The data presented thus far suggest that there was more basal GIRK activity in 308

    dorsal vs ventral neurons (Fig.2 and Fig.3). We next examined whether there was 309

    more basal activation of neurotransmitter receptors known to couple with GIRK 310

    channels in dorsal vs ventral neurons. In CA1 neurons, the activation of GABAB 311

    receptors, A1 adenosine receptors, and 5-HT1A serotonin receptors results in 312

    hyperpolarization of resting membrane potential by GIRK channels (Luscher et al. 313

    1997). Thus, it is possible that there is more activity in any one of these receptor 314

    systems in dorsal compared with ventral neurons. We first examined RMP and Rin in 315

    dorsal and ventral neurons during bath application of a potent and selective GABAB 316

  • 15

    receptors antagonist, CGP52432 (5 μM) (Lanza et al. 1993). There was no 317

    significant change in Vm and Rin (at RMP) up to 30-35 min after wash-in of 318

    CGP55845 in either dorsal (Fig.4, B and C; table 6) or ventral neurons (Fig.4, E and 319

    F; table 6). Because we did not observe any changes in Vm and Rin after blockade of 320

    GABAB receptors in dorsal or ventral neurons, we next applied a GABAB receptor 321

    agonist, baclofen, to test for the presence of functional GABAB receptors. Vm and Rin 322

    (at RMP) were monitored during 100 μM baclofen application in dorsal (Fig.4G) and 323

    ventral (Fig.4J) neurons. Baclofen significantly changed Vm (dorsal: Fig.4H; ventral: 324

    Fig.4K; table 6) and Rin (dorsal: Fig.4I; ventral: Fig.4L; table 6) in both dorsal and 325

    ventral neurons. The magnitude of changes in Vm (dorsal: -7.6±0.8 mV vs. ventral: -326

    8.2±0.6 mV; p>0.05; Fig.4M; n=6) and Rin at RMP (dorsal: -28.3±5.2 % vs. ventral: -327

    23.2±3.6 %; p>0.05; Fig.4N; n=6) was no significantly different after activation of 328

    GABAB receptors. 329

    330

    Effect of A1 adenosine receptor-mediated activation on GIRK conductance in 331

    dorsal CA1 neurons 332

    We next examined whether A1 adenosine receptors (A1ARs) are involved in 333

    the activation of the resting GIRK conductance in these neurons. 1,3-Dipropyl-8-334

    cyclopentylxanthine (DPCPX) is a selective A1 adenosine receptor antagonist 335

    (Alzheimer et al. 1989). Vm and Rin (at RMP) were monitored during 100 nM 336

    DPCPX wash-in in dorsal (Fig.5A) and ventral (Fig.5E) neurons. Dorsal neurons had 337

    significantly depolarized membrane potential (Fig.5, B and C; table 7) and an 338

    increased Rin at RMP (Fig.5, B and D; table 7) after blockade of A1 adenosine 339

  • 16

    receptors, whereas no changes were observed in ventral neurons (Fig.5, G and H; 340

    table 7). The magnitude of changes in Vm (dorsal 4.7±0.5 mV vs. ventral 1.1±0.5 mV; 341

    p

  • 17

    and B; n=3). Because there was a significant difference in A1AR protein expression 363

    in somatic region of dorsal and ventral CA1, we thus examined the effects by 2’ME-364

    CCPA, a selective A1 receptor agonist. Vm and Rin (at RMP) were monitored during 1 365

    μM 2’ME-CCPA application in the dorsal (Fig.7C) and ventral (Fig.7G) CA1 neurons. 366

    1 μM 2’ME-CCPA significantly hyperpolarized the membrane potential (Fig.7, D and 367

    E; table 9) and decreased Rin at RMP (Fig.7, D and F; table 9) in dorsal but not 368

    ventral neurons (Fig.7, H-J; table 9). The magnitude of changes in Vm (dorsal -369

    3.9±0.3 mV vs. ventral -0.3±0.3 mV; p

  • 18

    Discussion 384

    In this study, we examined the resting conductances that contribute to the 385

    different intrinsic membrane properties in dorsal and ventral CA1 neurons. We found 386

    that there was more Ba2+-sensitive conductance in dorsal than in ventral CA1 387

    neurons. Furthermore, Ba2+-dependent changes in Vm and Rin were due to block of 388

    GIRK channels. We also found that this resting GIRK conductance was mediated by 389

    A1 adenosine receptors in dorsal CA1 neurons, but not in ventral CA1 neurons. 390

    Until recently, the intrinsic electrophysiological properties of CA1 pyramidal 391

    neurons along the longitudinal hippocampal axis were assumed to be uniform. 392

    However, we and others have recently reported significant differences in the intrinsic 393

    electrophysiological properties between dorsal and ventral neurons (Dougherty et al. 394

    2012; Marcelin et al. 2012a). Although differences in the expression of some voltage-395

    gated ion channels between dorsal and ventral CA1 neurons have been reported 396

    (Marcelin et al. 2012b; Dougherty et al. 2013), the ionic mechanisms underlying the 397

    different intrinsic properties remain unclear. Because dorsal CA1 neurons showed a 398

    lower somatic Rin compared with ventral CA1 neurons, this could be due to more 399

    dendritic surface area for dorsal than ventral neurons (Dougherty et al. 2013), 400

    although Marcelin et al., reported that somatic and dendritic capacitances were not 401

    different between dorsal and ventral neurons (Marcelin et al. 2012a; Marcelin et al. 402

    2012b). A more hyperpolarized resting membrane potential in dorsal neurons 403

    compared to ventral neurons, however, could be due to dorsal CA1 neurons 404

    possessing a relatively larger resting potassium (K+) conductance, which could also 405

    contribute to a decrease in Rin. Indeed, low micromolar application of Ba2+ that 406

  • 19

    blocks inwardly rectifying K+ (KIR) channels (Chen and Johnston 2005) had 407

    significant effects of Vm and Rin (at RMP and at a common membrane potential -73 408

    mV) for dorsal neurons, but not for ventral neurons. In addition, the changes in V-I 409

    curves were greater for dorsal neurons than ventral neurons. It should be noted that 410

    higher concentrations of extracellular barium (Ba2+, > 200 µM) block A-type 411

    potassium channels (Gasparini et al. 2007), whereas low concentrations of barium 412

    (Ba2+, < 200 µM) are known to block inwardly rectifying potassium currents (Kir) 413

    (Standen and Stanfield 1978; Williams et al. 1988; Gerber et al. 1991; Chen and 414

    Johnston 2005). Furthermore, when 10 μM ZD7288 was applied after blockade of 415

    Ba2+-sensitive conductance, we observed that the change in Vm for ventral neurons 416

    was larger than dorsal neurons, consistent with more Ih in ventral CA1 neurons 417

    (Dougherty et al. 2013). Interestingly, the absolute values of Vm and Rin were similar 418

    between dorsal and ventral neurons after blockade of Ba2+-sensitive conductance 419

    and Ih, suggesting a larger Ba2+-sensitive conductance in dorsal neurons compared 420

    to ventral neurons and more Ih in ventral CA1 neurons compared to dorsal CA1 421

    neurons. Both Ba2+-sensitive conductance and Ih might account for these differences 422

    on intrinsic membrane properties between dorsal and ventral CA1 neurons. 423

    Two classes of inwardly rectifying potassium channels, Kir channels, are highly 424

    expressed in hippocampal neurons: IRK channels (Kir2.x), and GIRK channels 425

    (Kir3.x) (Karschin et al. 1996; Luscher et al. 1997; Chen and Johnston 2005). Both 426

    IRK and GIRK channels undergo voltage-dependent intracellular Mg2+ block, which 427

    imparts a rapid hyperpolarization-activated gating mechanism to these channels, and 428

    they become blocked and unblocked with depolarization and hyperpolarization, 429

  • 20

    respectively. Because dorsal CA1 neurons showed a larger response to a relatively 430

    low concentration of Ba2+ than ventral CA1 neurons, we used a specific GIRK 431

    channels blocker tertiapin-Q (Jin et al. 1999) in an attempt to identify molecular 432

    targets responsible for the resting Ba2+-sensitive conductance. Interestingly, we 433

    found that dorsal neurons showed significant changes in Vm and Rin (at RMP and at a 434

    common membrane potential -73 mV), but not ventral neurons after tertiapin-Q 435

    application, indicating that there was more basal GIRK conductance. Furthermore, 436

    when action potentials were elicited from a somatic current injection at a common 437

    membrane potential (-73 mV), tertiapin-Q application significantly increased action 438

    potential firing in dorsal neurons, but not in ventral neurons. In agreement with these 439

    results, the protein expression of GIRK1 and GIRK2 was significantly enriched in 440

    somatic and dendritic CA1 region of dorsal hippocampus compared to ventral 441

    hippocampus. The somatic and dendritic protein expression of GIRK subunits in the 442

    hippocampus have also been observed by other groups. (Liao et al. 1996). Most 443

    interestingly, successive tertiapin-Q and Ba2+ application revealed that a greater 444

    Ba2+-sensitive conductance for dorsal CA1 neurons stems from the GIRK 445

    conductance. 446

    Hippocampal G protein-coupled inwardly rectifying K+ (GIRK) channels are 447

    activated by a number of neurotransmitters systems, including GABAB receptors, 448

    serotonergic 5HT1A receptors, and adenosine A1 receptors (Andrade et al. 1986; 449

    North et al. 1987; North 1989; Luscher et al. 1997). Given that ventral neurons have 450

    a weaker GABAergic fast synaptic inhibition than dorsal CA1 neurons 451

    (Papatheodoropoulos et al. 2002), it is possible that there is more GABAB-mediated 452

  • 21

    slow tonic inhibition, which could activate more GIRK conductance in dorsal neurons 453

    compared to ventral neurons. We observed, however, that there are similar changes 454

    in Vm and Rin (at RMP) after activation of GABAB receptors in dorsal and ventral 455

    neurons, suggesting that coupling of GABAB receptors to GIRK channels might be 456

    similar. Lee et al. reported that dorsal CA1 region had a greater A1 adenosine 457

    receptor density, resulting in the suppression of extracellular excitatory postsynaptic 458

    potentials (EPSPs) in the presence of N6-cyclohexyladenosine, a selective A1 459

    adenosine receptor agonist, compared to ventral CA1 region (Lee et al. 1983). In 460

    accordance with these results, somatic whole-cell current-clamp recordings revealed 461

    that dorsal CA1 neurons showed significant changes in Vm and Rin in the presence of 462

    A1 adenosine receptor agonist or antagonist, but not in ventral neurons, suggesting 463

    again that A1 adenosine receptors are more heavily expressed in dorsal CA1 464

    neurons. Consistent with these results, the protein expression of A1 adenosine 465

    receptor was highly present in the somatic CA1 region of dorsal hippocampus 466

    compared with ventral hippocampus. Interestingly, when A1 adenosine receptors 467

    were blocked in dorsal neurons, the absolute values of Vm and Rin at RMP were 468

    similar to ventral neurons. Furthermore, successive Ba2+ and DPCPX application 469

    revealed that the activation of GIRK conductance is mediated by A1 adenosine 470

    receptors in dorsal CA1 neurons. These results suggest that A1 adenosine receptor-471

    mediated GIRK conductance might contribute to intrinsic membrane properties in 472

    dorsal CA1 neurons. 473

    Because GIRK and the adenosinergic system play important roles in the 474

    pathophysiology of diseases such as epilepsy, depression, and anxiety, our results 475

  • 22

    suggest that dorsal CA1 neurons/region (predominantly expressing A1 adenosine 476

    receptors-mediated GIRK conductance) might be important for chronic neurological 477

    disorders compared to ventral hippocampus. GIRK channels play an important role 478

    in regulating neuronal excitability (Signorini et al. 1997). The deletion of Kir3.2 479

    (GIRK2) channels led to an increase in susceptibility to a convulsant agent and 480

    showed sporadic seizures (Signorini et al. 1997). In the present study, we found that 481

    there is a more basal GIRK activity (i.e. physiological responses to specific GIRK 482

    channels blocker at RMP) in dorsal CA1 neurons compared to ventral CA1 neurons, 483

    which might contribute to different susceptibility to a convulsant agent within the 484

    hippocampus. Adenosinergic systems have been implicated in anxiety and 485

    depression. In preclinical studies, activation of adenosine A1 receptors led to 486

    antidepressant- and anxiolytic-like behaviors, whereas blockade of A1 adenosine 487

    receptors resulted in an increase in anxiety (Kaster et al. 2004; Prediger et al. 2006; 488

    Maximino et al. 2011). In a clinical study, large amount of caffeine, a non-selective A1 489

    adenosine receptor antagonist, are known to cause anxiety and depression in both 490

    normal and vulnerable subjects (Broderick and Benjamin 2004). Ligand-stimulated 491

    Gi/o protein-coupled receptors such as A1 adenosine receptors induce an inhibition of 492

    adenylyl cyclase, which results in a decrease in cAMP concentration (van Calker et 493

    al. 1978). Because HCN channels are modulated by cAMP, resulting in an increase 494

    in Ih (Wainger et al. 2001), stimulation of A1 adenosine receptors-induced decrease 495

    in cAMP levels might be interacting with HCN channels. 496

    Summary 497

    In summary, we have investigated the resting conductances that contribute to 498

  • 23

    intrinsic membrane properties of CA1 pyramidal neurons from the dorsal and ventral 499

    hippocampus. We found that dorsal CA1 neurons possess more basal activity of 500

    GIRK conductance, which was activated by A1 adenosine receptors. Our results 501

    suggest that A1 adenosine receptor-mediated GIRK conductance contributes to the 502

    different intrinsic membrane properties in dorsal and ventral CA1 pyramidal neurons. 503

    504

    505

    506

    507

    508

    509

    510

    511

    512

    513

    514

    515

    516

    517

    518

    519

    520

    521

  • 24

    Figure legends 522

    Fig.1. Dorsal neurons show greater response to Ba2+ compared with ventral CA1 523

    neurons. (A and E) Representative voltage responses with step current commands 524

    at RMP. (B and F) Time courses of changes in Vm and Rin during successive Ba2+ 525

    (50 μM) and ZD7288 (10 μM) wash-in experiments in dorsal (B) and ventral (F) CA1 526

    pyramidal neurons. (C and D) Dorsal CA1 pyramidal neurons showed a significantly 527

    depolarized Vm (C) and increased Rin (D) in the presence of Ba2+. Subsequent 528

    ZD7288 application resulted in a significantly hyperpolarized Vm (C) a further 529

    increase Rin (D). (G and H) Ventral CA1 pyramidal neurons showed no significant 530

    changes in Vm (G) and Rin (H) in the presence of Ba2+. Addition of ZD7288 led to a 531

    significantly hyperpolarized Vm (G) and an increased Rin (H). (I and J) The left 532

    displays representative voltage responses with step current commands at -73 mV. 533

    Dorsal CA1 neurons showed a significantly increased Rin, but not ventral CA1 534

    neurons at a common membrane potential (-73 mV) in the presence of Ba2+. (K and 535

    L) Dorsal CA1 neurons showed a more hyperpolarized RMP (K) and a lowered Rin at 536

    RMP (L) compared to ventral CA1 neurons. There is no difference in Vm (K) and Rin 537

    (L) between dorsal and ventral neurons following successive Ba2+ and ZD7288 538

    application. (M and N) Dorsal neurons showed significant changes in V-I curve 539

    before and after 50 μM Ba2+ application (M), but not ventral neurons (N). (O) The 540

    differences in V-I curves before and after 50 μM Ba2+ application are indicated. (p < 541

    0.05 and #p < 0.05 in dorsal vs. ventral groups). 542

    Fig.2. Dorsal CA1 neurons show a more basal GIRK activity than ventral CA1 543

    neurons. (A and C) Representative dorsal and ventral hippocampal slices 544

  • 25

    immunolabeled with antibodies against Kir 3.1 (A; GIRK1) and Kir 3.2 (C; GIRK2). 545

    Yellow boxes depict the region of the slice used for quantification of signal intensity 546

    (B and D) Quantification of Kir3.1 (B) and Kir3.2 (D) protein expression from 547

    perisomatic region to the distal dendritic region of CA1 from dorsal and ventral 548

    hippocampus. The protein expression of Kir3.1 (B) and Kir 3.2 (D) was significantly 549

    increased in somatic and distal dendritic region of CA1 from dorsal hippocampus 550

    compared to ventral hippocampus. Vertical blue bars highlight part of the CA1 radial 551

    axis that show significant differences in Kir 3.1 (B) and Kir 3.2 (D) protein expression 552

    between dorsal and ventral CA1 region. (E) Representative voltage responses with 553

    step current commands at RMP. (F and G) 0.3 μM tertiapin-Q significantly changed 554

    Vm and Rin, in dorsal but not ventral neurons. 2 μM tertiapin-Q produced similar 555

    effects on Vm and Rin compared to 0.3 μM tertiapin-Q wash-in in dorsal and ventral 556

    neurons. Dorsal CA1 neurons showed significant changes in Vm and Rin in the 557

    presence of 0.3 μM or 2 μM tertiapin-Q compared to ventral CA1 neurons. *p < 0.05 558

    and #p < 0.05 vs. ventral group. 559

    560

    Fig.3. Ba2+-sensitive conductance-mediated changes in Vm and Rin stem from GIRK 561

    conductance in dorsal CA1 neurons. (A and E) Representative voltage responses 562

    with step current commands at RMP are shown. (B and F) Time courses of changes 563

    in Vm and Rin during successive 0.3 μM tertiapin and 50 μM Ba2+ application in dorsal 564

    (B) and ventral (F) CA1 pyramidal neurons. (C and D) Dorsal CA1 neurons showed a 565

    significantly depolarized Vm (C) and an increased Rin (D) following bath application of 566

    tertiapin-Q (0.3 μM). Subsequent blockade of Ba2+-sensitive conductance showed no 567

  • 26

    significant changes in Vm (C) and Rin (D) in dorsal CA1 neurons. (G and H) Ventral 568

    CA1 neurons showed no significant changes in Vm and Rin in the presence of 569

    tertiapin-Q (0.3 μM). Further changes in Vm and Rin were not observed following 570

    blockade of Ba2+-sensitive conductance in ventral neurons. Blockade of tertiapin-Q 571

    and Ba2+-sensitive conductance produced a significantly depolarized Vm and 572

    increased Rin compared to baseline in ventral neurons. (I and J) The left displays 573

    representative voltage responses with step current commands at -73 mV. Dorsal 574

    CA1 neurons showed a significantly increased Rin (I), but not ventral CA1 neurons 575

    (J) at a common membrane potential (-73 mV) following successive tertiapin-Q and 576

    Ba2+ application. (K and L) Representative membrane potential responses with 577

    depolarizing current steps (300 pA for 750 ms) at a common membrane potential (-578

    73 mV). (K) Dorsal neurons showed significant increases in action potential firing 579

    after either tertiapin-Q or tertiapin-Q+Ba2+ application, but not ventral neurons (L). *p 580

    < 0.05. 581

    582

    Fig.4. Similar changes in Vm and Rin in the presence of GABAB receptor antagonist 583

    and agonist in dorsal and ventral CA1 neurons. (A and D) Time courses of changes 584

    in Vm and Rin during CGP55845 (5 μM) wash-in experiments in dorsal (A) and ventral 585

    (D) neurons. Dorsal (B and C) and ventral (E and F) neurons showed no changes in 586

    Vm and Rin in the presence of CGP55845. (G and J) Time courses of Vm and Rin in 587

    the presence of baclofen in dorsal (G) and ventral (J) neurons. Dorsal (H and I) and 588

    ventral (K and L) CA1 neurons showed a significantly hyperpolarized Vm and a 589

    decreased Rin following activation of GABAB receptors. The changes in Vm and Rin 590

  • 27

    were not significantly different in dorsal and ventral CA1 neurons in the presence of 591

    CGP55845 or baclofen. *p < 0.05. 592

    593

    Fig.5. Dorsal CA1 neurons showed greater responses to A1 adenosine receptor 594

    antagonist compared to ventral CA1 neurons. (A and E) Time course of changes in 595

    Vm and Rin during DPCPX (100 nM) wash-in experiments in dorsal (A) and ventral 596

    (E) neurons. (B and F) Representative voltage responses with step current 597

    commands at RMP are shown. (C and D) 100 nM DPCPX caused a significant 598

    depolarization in dorsal neurons (C) and an increased Rin (D). (G and H) Ventral 599

    neurons showed no changes in Vm (G) and Rin (H) after DPCPX (100 nM) wash-in. (I 600

    and J) The changes in Vm (I) and Rin (J) after 100 nM DPCPX wash-in were greater 601

    for dorsal neurons than ventral neurons. *p < 0.05 and #p < 0.05 vs. ventral group. 602

    603

    Fig.6. Dorsal CA1 neurons have an A1 adenosine receptor-mediated GIRK 604

    conductance. (A) Representative voltage responses with step current commands at 605

    RMP. (B) Time courses of changes in Vm and Rin during successive 50 μM Ba2+ and 606

    100 nM DPCPX in dorsal CA1 neurons. Dorsal CA1 neurons showed a significantly 607

    depolarized Vm (C) and an increased Rin (D) at RMP in the presence of Ba2+. 608

    Subsequent bath application of DPCPX had no further effects on Vm (C) and Rin (D) 609

    at RMP in dorsal neurons. (E) The left displays representative voltage responses 610

    with step current commands at -73 mV. Successive Ba2+ and DPCPX application led 611

    to a significantly increased Rin at a common membrane potential (-73 mV). *p < 0.05. 612

    613

  • 28

    Fig.7. A1 adenosine receptors and their physiological responses predominantly exist 614

    in dorsal, but not in ventral CA1 neurons. (A) Representative dorsal and ventral 615

    hippocampal slices immunolabeled with antibodies against A1 adenosine receptors. 616

    Yellow boxes depict the region of the slice used for quantification of signal intensity. 617

    (B) Quantification of A1ARs protein expression from perisomatic region to the distal 618

    dendritic region of CA1 from dorsal and ventral hippocampus. The protein 619

    expression of A1 adenosine receptors was highly present in somatic CA1 region of 620

    dorsal hippocampus, but not in ventral CA1 region. The blue shade indicates a 621

    significant difference in A1ARs protein expression between dorsal and ventral CA1 622

    region. (C and G) Time courses of Vm and Rin during 2’ME-CCPA (1 μM) wash-in 623

    experiments in dorsal (C) and ventral (G) CA1 neurons. (D and H) Representative 624

    voltage responses with step current commands at RMP. (E and F) Dorsal CA1 625

    neurons showed a significant hyperpolarization (E) and a decreased Rin at RMP (F) 626

    in the presence of 2’ME-CCPA (1 μM). (I and J) Ventral CA1 neurons showed no 627

    changes in Vm (I) and Rin at RMP (J) after 2’ME-CCPA (1 μM) wash-in. (K and L) The 628

    changes in Vm (K) and Rin (L) after 2’ME-CCPA (1 μM) application were greater for 629

    dorsal CA1 neurons than ventral CA1 neurons. (M and N) Activation of A1 adenosine 630

    receptors resulted in a significantly decreased Rin at a common membrane potential 631

    (-73 mV) in dorsal (M), but not in ventral (N) CA1 neurons. *p < 0.05 and #p < 0.05 vs. 632

    ventral group. 633

    634

    635

    636

  • 29

    Table 1. Subthreshold properties in successive 50 μM Ba2+ and 10 μM ZD7288 637

    application. (Related to Fig. 1) 638

    Dorsal CA1 Baseline 50 μM Ba2+

    wash-in

    10 μM ZD7288

    50 μM Ba2+ wash-in

    Vm (mV) -69.7±0.5 (n=7) -64.4±1.0 (n=7)* -71.0±0.7 (n=7)

    Rin (MΩ) 60.8±4.1 (n=7) 85.7±5.6 (n=7)* 166.4±9.0 (n=7)*

    Ventral CA1 Baseline 50 μM Ba2+

    wash-in

    10 μM ZD7288

    50 μM Ba2+ wash-in

    Vm (mV) -66.5±0.7 (n=7) -64.8±1.0 (n=7) -71.9±1.5 (n=7)*

    Rin (MΩ) 73.7±8.3 (n=7) 84.8±8.4 (n=7) 162.1±12.7 (n=7)*

    639

    Vm: membrane potential. Rin: Steady-state input resistance. * was considered as 640

    statistically significant (P

  • 30

    Table 2. Change in Rin at a common membrane potential (-73 mV) in dorsal and 655

    ventral CA1 neurons after 50 μM Ba2+ wash-in experiments. (Related to Fig. 1) 656

    Dorsal CA1 Baseline 50 μM Ba2+ Ventral CA1 Baseline 50 μM Ba2+

    Rin (MΩ)

    at -73 mV

    60.0±3.5

    (n=6) 72.1±4.2*

    (n=6)

    Rin (MΩ)

    at -73 mV

    69.1±5.1

    (n=7)

    72.6±7.2

    (n=7)

    657

    Rin: Steady-state input resistance. 658

    * was considered as statistically significant (P

  • 31

    Table 3. Dose-response tertiapin-Q experiment in dorsal and ventral CA1 neurons. 676

    (Related to Fig. 2) 677

    0.03 μM tertiapin-Q 0.3 μM tertiapin-Q 2 μM tertiapin-Q

    Dorsal CA1 Baseline Tertiapin Baseline Tertiapin Baseline Tertiapin

    Vm

    (mV)

    -69.9±1.0

    (n=7)

    -67.8±1.1

    (n=7)

    -69.0±0.5

    (n=7) -64.4±0.5*

    (n=7)

    -69.4±0.9

    (n=6) -65.4±0.9*

    (n=6)

    Rin

    (MΩ)

    60.2±2.8

    (n=7)

    70.5±3.5

    (n=7)

    62.9±1.2

    (n=7) 82.6±2.2*

    (n=7)

    64.5±3.9

    (n=6) 85.6±4.5*

    (n=6)

    0.03 μM tertiapin-Q 0.3 μM tertiapin-Q 2 μM tertiapin-Q

    Ventral CA1 Baseline Tertiapin Baseline Tertiapin Baseline Tertiapin

    Vm

    (mV)

    -65.3±1.0

    (n=6)

    -64.7±1.4

    (n=6)

    -64.9±0.5

    (n=6)

    -63.0±0.7

    (n=6)

    -64.1±0.8

    (n=6)

    -62.6±0.9

    (n=6)

    Rin

    (MΩ)

    82.5±4.8

    (n=6)

    87.2±5.8

    (n=6)

    87.3±3.0

    (n=6)

    95.8±2.7

    (n=6)

    85.0±4.8

    (n=6)

    89.1±3.9

    (n=6)

    678

    Vm: membrane potential. Rin: Steady-state input resistance. * was considered as 679

    statistically significant (P

  • 32

    Table 4. Subthreshold properties in subsequent tertiapin-Q and barium wash-in 690

    experiments. (Related to Fig. 3) 691

    Dorsal CA1 Baseline 0.3 μM Tertiapin-Q

    wash-in

    0.3 μM Tertiapin-Q

    50 μM Ba2+ wash-in

    Vm (mV) -68.0±0.6 (n=7) -63.3±0.7 (n=7)* -61.2±1.1 (n=7)*

    Rin (MΩ) 62.4±1.5 (n=7) 80.5±3.6 (n=7)* 92.7±4.7 (n=7)*

    Ventral CA1 Baseline 0.3 μM Tertiapin-Q

    wash-in

    0.3 μM Tertiapin-Q

    50 μM Ba2+ wash-in

    Vm (mV) -64.6±0.5 (n=5) -62.9±0.6 (n=5) -61.4±0.6 (n=5)*

    Rin (MΩ) 86.9±3.0 (n=5) 95.0±3.4 (n=5) 102±1.9 (n=5)*

    692

    Vm: membrane potential. Rin: Steady-state input resistance. * was considered as 693

    statistically significant (P

  • 33

    Table 5. Change in Rin at a common membrane potential (-73 mV) in dorsal and 705

    ventral CA1 neurons in subsequent tertiapin-Q and barium wash-in experiments. 706

    (Related to Fig. 3) 707

    Dorsal CA1 Baseline 0.3 μM Tertiapin-Q

    wash-in

    0.3 μM Tertiapin-Q

    50 μM Ba2+ wash-in

    Rin (MΩ) at -73 mV 52.7±1.3 (n=6) 60.5±1.6 (n=6)* 62.8±1.7 (n=6)*

    Ventral CA1 Baseline 0.3 μM Tertiapin-Q

    wash-in

    0.3 μM Tertiapin-Q

    50 μM Ba2+ wash-in

    Rin (MΩ) at -73 mV 72.5±1.6 (n=5) 74.1±3.4 (n=5) 78.1±4.1 (n=5)

    708

    Rin: Steady-state input resistance. * was considered as statistically significant 709

    (P

  • 34

    Table 6. Subthreshold membrane properties in 5 μM CGP55845 or 100 μM baclofen 721

    wash-in experiments. (Related to Fig. 4) 722

    Dorsal CA1 Baseline 5 μM

    CGP55845

    Ventral CA1 Baseline 5 μM

    CGP55845

    Vm (mV) -70.0±0.8

    (n=4)

    -70.2±0.9

    (n=4)

    Vm (mV) -64.7±0.4

    (n=4)

    -64.2±0.5

    (n=4)

    Rin (MΩ)

    62.7±2.7

    (n=4)

    64.5±3.3

    (n=4)

    Rin (MΩ)

    86.4±4.0

    (n=4)

    89.6±4.0

    (n=4)

    Dorsal CA1 Baseline 100 μM

    baclofen

    Ventral CA1 Baseline 100 μM

    baclofen

    Vm (mV) -69.4±1.6

    (n=6)

    -76.6±1.0*

    (n=6)

    Vm (mV) -66.1±0.7

    (n=6)

    -74.4±1.0*

    (n=6)

    Rin (MΩ)

    66.6±5.7

    (n=6)

    46.5±2.1*

    (n=6)

    Rin (MΩ)

    83.2±5.7

    (n=6)

    63.1±3.4*

    (n=6)

    723

    Vm: membrane potential. Rin: Steady-state input resistance. * was considered as 724

    statistically significant (P

  • 35

    Table 7. Subthreshold membrane properties in 100 nM DPCPX wash-in experiments. 733

    (Related to Fig. 5) 734

    Dorsal CA1 Baseline DPCPX Ventral CA1 Baseline DPCPX

    RMP (mV) -69.0±0.7

    (n=7) -64.2±0.5*

    (n=7)

    RMP (mV) -64.7±0.7

    (n=6)

    -63.6±0.8

    (n=6)

    Rin (MΩ)

    66.4±4.9

    (n=7) 89.3±5.0*

    (n=7)

    Rin (MΩ)

    84.8±7.0

    (n=6)

    87.2±7.2

    (n=6)

    735

    Vm: membrane potential. Rin: Steady-state input resistance. * was considered as 736

    statistically significant (P

  • 36

    Table 8. Subthreshold membrane properties in successive Ba2+ and DPCPX wash-in 749

    experiments. (Related to Fig. 6) 750

    Dorsal CA1 Baseline 50 μM Ba2+

    wash-in

    100 nM DPCPX

    50 μM Ba2+ wash-in

    Vm (mV) -68.5±0.6 (n=7) -62.8±0.7 (n=7)* -62.4±0.6 (n=7)*

    Rin (MΩ) 69.8±2.5 (n=7) 99.7±4.9 (n=7) 103.7±5.0 (n=7)*

    Rin (MΩ) at -73 mV 58.8±2.4 (n=7) 65.8±2.2 (n=7) 69.1±2.6 (n=7)*

    751

    Vm: membrane potential. Rin: Steady-state input resistance. * was considered as 752

    statistically significant (P

  • 37

    Table 9. Subthreshold membrane properties in 2’ME-CCPA wash-in experiments. 766

    (Related to Fig. 7) 767

    Dorsal CA1 Baseline 2’ME-CCPA Ventral CA1 Baseline 2’ME-CCPA

    Vm (mV) -68.5±0.8

    (n=6) -72.3±0.9*

    (n=6)

    Vm (mV) -65.0±0.9

    (n=6)

    -65.3±0.94

    (n=6)

    Rin (MΩ)

    60.8±3.8

    (n=6) 50.2±3.2*

    (n=6)

    Rin (MΩ)

    75.2±5.4

    (n=6)

    75.4±6.0

    (n=6)

    Rin (MΩ)

    at -73 mV

    56.0±3.3

    (n=6) 50.5±3.1*

    (n=6)

    Rin (MΩ)

    at -73 mV

    60.2±3.6

    (n=5)

    60.6.±3.1

    (n=5)

    768

    Vm: membrane potential. Rin: Steady-state input resistance. * was considered as 769

    statistically significant (P

  • 38

    References 781 782

    Alzheimer C, Sutor B, and ten Bruggencate G. Transient and selective blockade of adenosine A1-783 receptors by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) causes sustained epileptiform activity in 784 hippocampal CA3 neurons of guinea pigs. Neurosci Lett 99: 107-112, 1989. 785 Andrade R, Malenka RC, and Nicoll RA. A G protein couples serotonin and GABAB receptors to the 786 same channels in hippocampus. Science 234: 1261-1265, 1986. 787 Armstrong CM, and Taylor SR. Interaction of barium ions with potassium channels in squid giant 788 axons. Biophys J 30: 473-488, 1980. 789 Broderick P, and Benjamin AB. Caffeine and psychiatric symptoms: a review. The Journal of the 790 Oklahoma State Medical Association 97: 538-542, 2004. 791 Chen X, and Johnston D. Constitutively active G-protein-gated inwardly rectifying K+ channels in 792 dendrites of hippocampal CA1 pyramidal neurons. J Neurosci 25: 3787-3792, 2005. 793 Day M, Carr DB, Ulrich S, Ilijic E, Tkatch T, and Surmeier DJ. Dendritic excitability of mouse frontal 794 cortex pyramidal neurons is shaped by the interaction among HCN, Kir2, and Kleak channels. J 795 Neurosci 25: 8776-8787, 2005. 796 Dong HW, Swanson LW, Chen L, Fanselow MS, and Toga AW. Genomic-anatomic evidence for 797 distinct functional domains in hippocampal field CA1. Proc Natl Acad Sci U S A 106: 11794-11799, 798 2009. 799 Dougherty KA, Islam T, and Johnston D. Intrinsic excitability of CA1 pyramidal neurones from the 800 rat dorsal and ventral hippocampus. J Physiol 590: 5707-5722, 2012. 801 Dougherty KA, Nicholson DA, Diaz L, Buss EW, Neuman KM, Chetkovich DM, and Johnston D. 802 Differential expression of HCN subunits alters voltage-dependent gating of h-channels in CA1 803 pyramidal neurons from dorsal and ventral hippocampus. J Neurophysiol 109: 1940-1953, 2013. 804 Drake CT, Bausch SB, Milner TA, and Chavkin C. GIRK1 immunoreactivity is present 805 predominantly in dendrites, dendritic spines, and somata in the CA1 region of the hippocampus. Proc 806 Natl Acad Sci U S A 94: 1007-1012, 1997. 807 Fanselow MS, and Dong HW. Are the dorsal and ventral hippocampus functionally distinct 808 structures? Neuron 65: 7-19, 2010. 809 Gasparini S, Losonczy A, Chen X, Johnston D, and Magee JC. Associative pairing enhances 810 action potential back-propagation in radial oblique branches of CA1 pyramidal neurons. J Physiol 580: 811 787-800, 2007. 812 Gerber U, Stevens DR, McCarley RW, and Greene RW. Muscarinic agonists activate an inwardly 813 rectifying potassium conductance in medial pontine reticular formation neurons of the rat in vitro. J 814 Neurosci 11: 3861-3867, 1991. 815 Hoffman DA, Magee JC, Colbert CM, and Johnston D. K+ channel regulation of signal propagation 816 in dendrites of hippocampal pyramidal neurons. Nature 387: 869-875, 1997. 817 Jin W, Klem AM, Lewis JH, and Lu Z. Mechanisms of inward-rectifier K+ channel inhibition by 818 tertiapin-Q. Biochemistry 38: 14294-14301, 1999. 819 Karschin C, Dissmann E, Stuhmer W, and Karschin A. IRK(1-3) and GIRK(1-4) inwardly rectifying 820 K+ channel mRNAs are differentially expressed in the adult rat brain. J Neurosci 16: 3559-3570, 1996. 821 Kaster MP, Rosa AO, Rosso MM, Goulart EC, Santos AR, and Rodrigues AL. Adenosine 822 administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and 823 A2A receptors. Neurosci Lett 355: 21-24, 2004. 824 Kim CS, Chang PY, and Johnston D. Enhancement of dorsal hippocampal activity by knockdown of 825 HCN1 channels leads to anxiolytic- and antidepressant-like behaviors. Neuron 75: 503-516, 2012. 826 Lanza M, Fassio A, Gemignani A, Bonanno G, and Raiteri M. CGP 52432: a novel potent and 827 selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur J Pharmacol 237: 191-195, 1993. 828 Lee KS, Schubert P, Reddington M, and Kreutzberg GW. Adenosine receptor density and the 829 depression of evoked neuronal activity in the rat hippocampus in vitro. Neurosci Lett 37: 81-85, 1983. 830 Liao YJ, Jan YN, and Jan LY. Heteromultimerization of G-protein-gated inwardly rectifying K+ 831 channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain. J Neurosci 16: 832 7137-7150, 1996. 833 Luscher C, Jan LY, Stoffel M, Malenka RC, and Nicoll RA. G protein-coupled inwardly rectifying K+ 834 channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal 835 neurons. Neuron 19: 687-695, 1997. 836

  • 39

    Magee JC. Dendritic hyperpolarization-activated currents modify the integrative properties of 837 hippocampal CA1 pyramidal neurons. J Neurosci 18: 7613-7624, 1998. 838 Marcelin B, Liu Z, Chen Y, Lewis AS, Becker A, McClelland S, Chetkovich DM, Migliore M, 839 Baram TZ, Esclapez M, and Bernard C. Dorsoventral differences in intrinsic properties in developing 840 CA1 pyramidal cells. J Neurosci 32: 3736-3747, 2012a. 841 Marcelin B, Lugo JN, Brewster AL, Liu Z, Lewis AS, McClelland S, Chetkovich DM, Baram TZ, 842 Anderson AE, Becker A, Esclapez M, and Bernard C. Differential dorso-ventral distributions of 843 Kv4.2 and HCN proteins confer distinct integrative properties to hippocampal CA1 pyramidal cell distal 844 dendrites. J Biol Chem 287: 17656-17661, 2012b. 845 Maximino C, Lima MG, Olivera KR, Picanco-Diniz DL, and Herculano AM. Adenosine A1, but not 846 A2, receptor blockade increases anxiety and arousal in Zebrafish. Basic & clinical pharmacology & 847 toxicology 109: 203-207, 2011. 848 Mihara S, North RA, and Surprenant A. Somatostatin increases an inwardly rectifying potassium 849 conductance in guinea-pig submucous plexus neurones. J Physiol 390: 335-355, 1987. 850 Moser MB, and Moser EI. Functional differentiation in the hippocampus. Hippocampus 8: 608-619, 851 1998. 852 North RA. Twelfth Gaddum memorial lecture. Drug receptors and the inhibition of nerve cells. Br J 853 Pharmacol 98: 13-28, 1989. 854 North RA, Williams JT, Surprenant A, and Christie MJ. Mu and delta receptors belong to a family 855 of receptors that are coupled to potassium channels. Proc Natl Acad Sci U S A 84: 5487-5491, 1987. 856 Papatheodoropoulos C, Asprodini E, Nikita I, Koutsona C, and Kostopoulos G. Weaker synaptic 857 inhibition in CA1 region of ventral compared to dorsal rat hippocampal slices. Brain Res 948: 117-121, 858 2002. 859 Ponce A, Bueno E, Kentros C, Vega-Saenz de Miera E, Chow A, Hillman D, Chen S, Zhu L, Wu 860 MB, Wu X, Rudy B, and Thornhill WB. G-protein-gated inward rectifier K+ channel proteins (GIRK1) 861 are present in the soma and dendrites as well as in nerve terminals of specific neurons in the brain. J 862 Neurosci 16: 1990-2001, 1996. 863 Prediger RD, da Silva GE, Batista LC, Bittencourt AL, and Takahashi RN. Activation of adenosine 864 A1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice. 865 Neuropsychopharmacology 31: 2210-2220, 2006. 866 Quayle JM, Standen NB, and Stanfield PR. The voltage-dependent block of ATP-sensitive 867 potassium channels of frog skeletal muscle by caesium and barium ions. J Physiol 405: 677-697, 868 1988. 869 Sah P. Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation. Trends 870 Neurosci 19: 150-154, 1996. 871 Signorini S, Liao YJ, Duncan SA, Jan LY, and Stoffel M. Normal cerebellar development but 872 susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2. 873 Proc Natl Acad Sci U S A 94: 923-927, 1997. 874 Spruston N. Pyramidal neurons: dendritic structure and synaptic integration. Nature reviews 875 Neuroscience 9: 206-221, 2008. 876 Standen NB, and Stanfield PR. A potential- and time-dependent blockade of inward rectification in 877 frog skeletal muscle fibres by barium and strontium ions. J Physiol 280: 169-191, 1978. 878 Stuart GJ, Dodt HU, and Sakmann B. Patch-clamp recordings from the soma and dendrites of 879 neurons in brain slices using infrared video microscopy. Pflugers Arch 423: 511-518, 1993. 880 van Calker D, Muller M, and Hamprecht B. Adenosine inhibits the accumulation of cyclic AMP in 881 cultured brain cells. Nature 276: 839-841, 1978. 882 van Groen T, and Wyss JM. Extrinsic projections from area CA1 of the rat hippocampus: olfactory, 883 cortical, subcortical, and bilateral hippocampal formation projections. J Comp Neurol 302: 515-528, 884 1990. 885 Vetter P, Roth A, and Hausser M. Propagation of action potentials in dendrites depends on dendritic 886 morphology. J Neurophysiol 85: 926-937, 2001. 887 Wainger BJ, DeGennaro M, Santoro B, Siegelbaum SA, and Tibbs GR. Molecular mechanism of 888 cAMP modulation of HCN pacemaker channels. Nature 411: 805-810, 2001. 889 Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, Dixon JE, and McKinnon D. KCNQ2 890 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282: 1890-891 1893, 1998. 892

  • 40

    Williams JT, North RA, and Tokimasa T. Inward rectification of resting and opiate-activated 893 potassium currents in rat locus coeruleus neurons. J Neurosci 8: 4299-4306, 1988. 894 895 896

  • ADorsal CA1 neurons

    Ventral CA1 neurons

    050

    100150200250

    Baseline Ba2+

    Rni

    M(

    50 μM Ba2+ 50 μM Ba2+

    10 μM ZD728850 μM Ba2+

    -80

    -75

    -70

    -65

    -60

    Vm

    )V

    m(

    0

    50

    100

    150

    200

    250R

    ni)

    ΩM(

    VmRin

    -90

    -80

    -70

    -60

    Baseline Ba2+ ZD7288Ba2+

    Vm

    )V

    m(

    Baseline Ba2+ ZD7288Ba2+

    050

    100150200250

    Rni

    M(

    -80

    -75

    -70

    -65

    -60

    Vm

    )V

    m(

    0

    50

    100

    150

    200

    250

    Rni

    M(

    Time (min)12 16 20 24 32 36 40 44 48

    50 μM Ba2+ 50 μM Ba2+

    10 μM ZD728850 μM Ba2+Vm

    RinB

    Baseline50 μM Ba2+

    10 μM ZD728850 μM Ba2+

    200 ms

    Vm 01

    -70mV

    -64mV

    -72mV

    Baseline 50 μM Ba2+

    10 μM ZD728850 μM Ba2+

    200 ms

    Vm 01

    -66mV

    -64mV

    -71mV

    C D

    E

    F G H

    ***

    * *

    **

    -90

    -80

    -70

    -60

    Baseline Ba2+ ZD7288Ba2+

    Vm

    )V

    m(

    **

    I

    J

    ZD7288Ba2+

    -80

    -75

    -70

    -65

    -60

    Vm

    )V

    m(

    enilesaB aB+2

    8827DZ aB

    +2

    Dorsal CA1 Ventral CA1

    0

    50

    100

    150

    200

    Rni

    M(

    #

    #

    enilesaB aB+2

    8827DZ aB

    +2

    enilesaBaB

    +2 8827DZ aB+2

    enilesaBaB

    +2 8827DZ aB+2

    -73 mV

    -73 mV

    200 ms

    Vm 01

    200 ms

    Vm 01

    -150 pA

    10 pAIinj

    Baseline

    50 μM Ba2+

    Baseline

    50 μM Ba2+

    Baseline Ba2+0

    2040

    6080

    100

    Rni

    Vm 37- ta )

    ΩM(

    Baseline Ba2+0

    2040

    6080

    100

    Rni

    Vm 37- ta )

    ΩM (

    *K

    L

    -150 pA

    10 pAIinj

    -150 pA

    10 pAIinj

    Time (min)11 15 19 23 34 38 42 46 50

    Vm(m

    V)

    M

    BaselineBa2+

    -150 -100 -50

    -15

    -10

    -5

    5

    Vm(m

    V)

    Injected Current (pA)

    At -73mV

    -150 -100 -50

    -15

    -10

    -5

    5

    Vm(m

    V)

    Injected Current (pA)

    At RMP

    Ventral CA1 neuronsN

    -150 -100 -50

    -15

    -5

    5

    BaselineBa2+

    -150 -100 -50

    -15

    -10

    -5

    5

    Vm(m

    V)

    Injected Current (pA) Injected Current (pA)

    At RMP At -73mV

    Dorsal CA1 neurons

    * *

    -150 -100 -50

    -5-4-3-2-1

    1

    DorsalVentral

    At RMP

    ∆Vm(m

    V)

    (Bas

    elin

    e- B

    a2+ )

    Injected Current (pA)

    *

    O-150 -100 -50

    -5-4-3-2-1

    1

    At -73mVInjected Current (pA)

    * ∆Vm(m

    V)

    (Bas

    elin

    e- B

    a2+ )

    DorsalVentral

  • Dorsal CA1

    2

    4

    6

    8

    10

    0

    Cha

    nge

    in V

    m (m

    V)

    (Bas

    elin

    e - T

    ertia

    pin-

    Q)

    **

    #

    0.03 0.3 2

    Ventral CA1

    Tertiapin-Q (μM) 0

    .03 0.3 2

    0

    20

    40

    60

    80

    100

    Cha

    nge

    in R

    in(%

    )(B

    asel

    ine-

    Terti

    apin

    -Q)

    **

    Dorsal CA1

    0.03 0.3 2

    Ventral CA1

    Tertiapin-Q (μM) 0

    .03 0.3 2

    F G

    0.03 μM Tertiapin-Q

    -70 mV

    -150 pA

    10 pA

    -68.9mV

    -69 mV

    -64.6 mV -69.4

    mV

    -64.8 mV

    10 m

    V

    200 ms

    0.3 μM Tertiapin-Q 2 μM Tertiapin-Q

    E

    Before After Before After Before After

    -66 mV

    -65.3 mV

    -65 mV

    -63.7 mV

    -66 mV

    -64.5 mV

    10 m

    V

    200 ms-150 pA

    10 pA

    0.03 μM Tertiapin-Q 0.3 μM Tertiapin-Q 2 μM Tertiapin-Q

    Before After Before After Before After

    Dorsal CA1 neurons

    Ventral CA1 neurons

    ##

    AKir3.1 (GIRK1)

    Kir3.2 (GIRK2)

    500 μm

    500 μm

    Kir3.1 Kir3.1

    Kir3.2 Kir3.2

    Dorsal Ventral

    Dorsal Ventral

    SOSPSRSLM

    SPSO

    SR

    SLM

    B

    C D

    * *

    Normalized Relative Distancein CA1 region

    Rel

    ativ

    e In

    tens

    ity(A

    rbitr

    ary

    Uni

    t)

    Dorsal CA1Ventral CA1

    SP SR SLM

    0 0.5 1.00

    50

    100

    150

    Rel

    ativ

    e In

    tens

    ity(A

    rbitr

    ary

    Uni

    t)

    0 0.5 1.00

    50

    100

    150

    SP SR SLM

    Dorsal CA1Ventral CA1

    *

    Normalized Relative Distancein CA1 region

    SP SL

    SP

    *

    L

    Iinj

    Iinj

    #

  • -70 mV Vm 01

    200 ms

    -150 pA

    10 pA

    -65 mV -63 mV

    Baseline 0.3 μM Tertiapin-Q0.3 μM Tertiapin-Q

    50 μM Ba2+

    *

    50

    100

    150

    Rni

    M (

    *

    -80

    -70

    -60

    -50

    Vm

    )V

    m(

    eniilesaB

    Q-nipaitreT

    Q-nipaitreT

    aB

    +2

    -66 mV -64 mV-62 mV

    Vm 01

    200 ms

    -150 pA

    10 pA

    *

    -80

    -70

    -60

    -50

    A

    Rni

    M(

    60

    80

    100

    14 18 2210Time (min)

    -75

    -70

    -65

    -60

    Vm

    )V

    m(

    120

    140

    26 30 38 42 46 51 55

    VmRin

    0.3 μM Tertiapin-Q

    60

    80

    100

    9 13 17 21Time (min)

    -75

    -70

    -65

    -60

    120

    140

    25 29 3640 44 4852

    VmRin

    B C D

    E

    F G H0.3 μM Tertiapin-Q

    50 μM Ba2+

    50 μM Ba2+

    Baseline 0.3 μM Tertiapin-Q0.3 μM Tertiapin-Q

    50 μM Ba2+

    Ventral CA1 neurons

    Dorsal CA1 neurons

    -73 mV

    Vm 01

    200 ms

    -150 pA

    10 pA

    Baseline

    0.3 μM Tertiapin-Q

    0.3 μM Tertiapin-Q50 μM Ba2+

    -150 pA

    10 pA

    IVentral CA1 neuronsDorsal CA1 neurons

    0

    20

    40

    60

    80

    100

    eniilesaB

    Q-nipaitreT

    Q-nipaitreT

    aB

    +2

    Rni

    Vm 37- ta )

    ΩM(

    **

    0

    20

    40

    60

    80

    100

    Rni

    Vm 37- ta )

    ΩM(

    JBaseline

    0.3 μM Tertiapin-Q

    0.3 μM Tertiapin-Q50 μM Ba2+

    -73 mV

    Vm 01

    200 ms

    **

    *

    0

    50

    100

    150

    0

    Iinj

    Iinj

    Rni

    M(

    Vm

    )V

    m(

    Rni

    M(

    Vm

    )V

    m(

    eniilesaB

    Q-nipaitreT

    Q-nipaitreT

    aB

    +2

    eniilesaB

    Q-nipaitreT

    Q-nipaitreT

    aB

    +2 eniilesaB

    Q-nipaitreT

    Q-nipaitreT

    aB

    +2

    eniilesaB

    Q-nipaitreT

    Q-nipaitreT

    aB

    +2

    Iinj Iinj

    0

    5

    10

    15

    20

    # of

    AP

    s

    0 60 120 180 240 300Injected Current (pA)

    0 60 120 180 240 3000

    5

    10

    15

    20

    Injected Current (pA)

    # of

    AP

    s

    BaselineTertiapin-QTertiapin-Q + Ba2+

    -73 mV -73 mV

    Dorsal CA1 neurons Ventral CA1 neuronsBaseliine 0.3 μM Tertiapin-Q 50 μM Ba2+

    20 m

    V

    200 ms

    20 m

    V

    200 ms

    Baseliine 0.3 μM Tertiapin-Q 50 μM Ba2+

    K L

    *

    300 pA 300 pA

    0.3 μM Tertiapin-Q 0.3 μM Tertiapin-Q

    BaselineTertiapin-QTertiapin-Q + Ba2+

  • DADorsal CA1 neurons Ventral CA1 neurons

    Time (min)

    Vm

    Rin

    0

    50

    120

    -80

    -70

    -60

    0 8 16

    Vm (m

    V) R

    in

    24

    VmRin

    -85

    -75

    -65

    -55

    Baseline Baclofen

    *

    -85

    -75

    -65

    -55 *

    0

    50

    100

    150*

    0

    50

    100

    150 *

    32

    5 μM CGP55845

    100

    5 μM CGP55845

    Vm (m

    V)

    -75

    -70

    -65

    -60

    Baseline CGP55845

    0

    50

    100

    150

    Rin

    Baseline CGP55845

    0

    50

    100

    150

    Baseline CGP55845

    -75

    -70

    -65

    -60

    Baseline CGP55845

    Time (min)

    0

    50

    120

    -80

    -70

    -60

    0 8 16 24 32

    100

    B C E F

    Baseline Baclofen Baseline Baclofen Baseline Baclofen

    0

    30

    60

    90

    120

    -80

    -70

    -60

    Time (min)0 2 4 6 8

    0

    30

    60

    90

    120

    -80

    -70

    -60

    Time (min)0 2 4 6 8

    100 μM Baclofen 100 μM Baclofen

    JG

    H I K L

    M N

    Cha

    nge

    in R

    in (%

    ) 0-20

    -40

    -60

    -80

    -100

    Dorsal VentralDorsal Ventral

    -10

    -8

    -6

    -4

    -2

    0

    Cha

    nge

    in V

    m (m

    V)

    Baclofen Baclofen

    Dorsal CA1 neurons Ventral CA1 neurons

    Rin

    Vm (m

    V)

    Vm (m

    V)

    Rin

    Vm

    RinVmRin

    Vm (m

    V) R

    in

    Rin

    Vm (m

    V)

    Vm (m

    V)

    Rin V

    m (m

    V)

    Rin

  • EADorsal CA1 neurons Ventral CA1 neurons

    -67 mV -67 mV-70 mV

    -150 pA

    10 pA

    5 m

    V

    200 ms

    -65 mV

    Baseline 100 nM DPCPX Baseline

    -150 pA

    10 pA

    100 nM DPCPX

    5 m

    V

    200 ms

    *

    -80

    -70

    -60

    -50

    Vm(m

    V)

    Baseline DPCPX-80

    -70

    -60

    -50

    Baseline DPCPX0

    50

    100

    150

    Rin

    Baseline DPCPX

    *

    0

    50

    100

    150

    Baseline DPCPX

    Time (min)

    VmRin

    406080100120140

    -80

    -75

    -70

    -65

    -60

    0 5 10 15 20

    Vm (m

    V) Rin

    100 nM DPCPX

    Time (min)

    VmRin

    406080100120140

    -80

    -75

    -70

    -65

    -60

    0 5 10 15 20

    100 nM DPCPX

    Cha

    nge

    in R

    in (%

    )

    Dorsal Ventral0

    20

    40

    60

    80

    100

    B

    C D

    F

    G H

    0

    2

    4

    6

    8

    10

    Dorsal Ventral

    Cha

    nge

    in V

    m (m

    V)

    # #

    I JV

    m (m

    V) Rin

    Iinj Iinj

    Vm(m

    V)

    Rin

  • Baseline Ba2+ DPCPXBa2+

    -80

    -70

    -60

    -50

    Vm (m

    V)

    0

    50

    100

    150

    Rin���

    ��

    Baseline Ba2+ DPCPXBa2+

    VmRin

    B

    C D **

    **

    m

    0

    50

    100

    -80

    -70

    -60

    -50

    Vm (m

    V)

    150-40

    10 14 18

    Time (min)22

    50 μM Ba2+ 50 μM Ba2+100 nM DPCPX

    Rin ���

    ��

    -70 mV

    10 m

    V

    200 ms

    -150 pA

    10 pA

    -64 mV -64 mV

    Baseline 50 μM Ba2+100 nM DPCPX

    50 �M Ba2+A

    Dorsal CA1 neurons

    -73 mV

    -150 pA

    10 pA

    Baseline

    50 μM Ba2+

    100 nM DPCPX50 �M Ba2+

    E

    10 m

    V

    200 ms

    Basel

    iine Ba2+

    DPCP

    X

    Ba2

    +

    **

    0

    20

    40

    60

    80

    100

    Rin���

    ���

    ���

    ���

    26 37 41 45 49 53

    Iinj

    Iinj

  • GCDorsal CA1 neurons Ventral CA1 neurons

    -66 mV -67 mV-69 mV

    -150 pA

    10 pA

    -73 mV

    Baseline 1 μM 2’ME-CCPA Baseline

    -150 pA

    10 pA

    5 m

    V

    200 ms

    -80

    -70

    -60

    -50

    Vm

    (mV

    )

    Baseline 2’ME-CCPA-80

    -70

    -60

    -50

    0

    50

    100

    150

    Rin���

    ��

    *

    0

    50

    100

    150

    Cha

    nge

    in R

    in (%

    )

    Dorsal Ventral0

    20

    40

    60

    80

    100

    D

    E F

    H

    I J

    K LDorsal Ventral

    #-5

    -4

    -3

    -2

    -1

    0

    Cha

    nge

    in V

    m (m

    V)

    Baseline 2’ME-CCPABaseline 2’ME-CCPA Baseline 2’ME-CCPA

    5 m

    V

    200 ms

    1 μM 2’ME-CCPA

    Time (min)

    VmRin

    020406080100

    -80

    -75

    -70

    -65

    -60

    10 12 14 16 18

    Vm (m

    V) Rin ���

    ��

    1 μM 2’ME-CCPA

    20 22

    VmRin

    0

    20406080100

    -80

    -75

    -70

    -65

    -60

    1 μM 2’ME-CCPA

    Time (min)11 13 15 17 19 21 23 25

    *

    #

    020406080

    100

    Rin��

    ��

    ��

    ����

    Baseline 2’ME-CCPA

    *

    020406080

    100

    Rin��

    ��

    ��

    ����

    Baseline 2’ME-CCPA

    M NDorsal

    CA1 neuronsVentral

    CA1 neurons

    Vm (m

    V) Rin ���

    ��

    Iinj Iinj

    Vm

    (mV

    )

    Rin���

    ��

    500 μm

    A1 ARDorsal

    SOSPSRSLM

    A1 ARVentral

    500 μm

    Normalized Relative Distancein CA1 region

    Rel

    ativ

    e In

    tens

    ity(A

    rbitr

    ary

    Uni

    t)

    Dorsal CA1Ventral CA1

    0 0.5 1.00

    50

    100

    150*

    SP SR SLM

    200SOSP

    SRSLM

    SO

    SSL

    A B

    Article FileFigure 1Figure 2Figure 3Figure 4Figure 5Figure 6Figure 7